Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ETON O' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bedikian, AY; Plager, C; Stewart, JR; O'Brian, CA; Herdman, SK; Ross, M; Papadopoulos, N; Eton, O; Ellerhorst, J; Smith, T
      Phase II evaluation of bryostatin-1 in metastatic melanoma

      MELANOMA RESEARCH
    2. Grimm, EA; Smid, CM; Lee, JJ; Tseng, CH; Eton, O; Buzaid, AC
      Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy

      CLINICAL CANCER RESEARCH
    3. Eton, O; Buzaid, AC; Bedikian, AY; Smith, TM; Papadopoulos, NE; Ellerhorst, JA; Hibberts, JL; Legha, SS; Benjamin, RS
      A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

      CANCER
    4. Ellerhorst, JA; Bedikian, A; Ring, S; Buzaid, AC; Eton, O; Legha, SS
      Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

      ONCOLOGY REPORTS
    5. Bedikian, AY; Legha, SS; Eton, O; Buzaid, AC; Papadopoulos, N; Plager, C; McIntyre, S; Viallet, J
      Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma

      ANTI-CANCER DRUGS
    6. ETON O; KHARKEVITCH DD; GIANAN MA; ROSS MI; ITOH K; PRIDE MW; DONAWHO C; BUZAID AC; MANSFIELD PF; LEE JE; LEGHA SS; PLAGER C; PAPADOPOULOS NE; BEDIKIAN AY; BENJAMIN RS; BALCH CM
      ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA

      Clinical cancer research
    7. ETON O; KHARKEVITCH DD; GIANAN MA; ROSS MI; ITOH K; PRIDE MW; DONAWHO C; BUZAID AC; MANSFIELD PF; LEE JE; LEGHA SS; PLAGER C; PAPADOPOULOS NE; BEDIKIAN AY; BENJAMIN RS; BALCH CM
      ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA

      Clinical cancer research
    8. PRIDE MW; SHUEY S; GRILLOLOPEZ A; BRASLAWSKY O; ROSS M; LEGHA SS; ETON O; BUZAID A; IOANNIDES C; MURRAY JL
      ENHANCEMENT OF CELL-MEDIATED-IMMUNITY IN MELANOMA PATIENTS IMMUNIZED WITH MURINE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES (MELIMMUNE(R)) THAT MIMIC THE HIGH-MOLECULAR-WEIGHT PROTEOGLYCAN ANTIGEN

      Clinical cancer research
    9. BUZAID AC; ALIOSMAN F; AKANDE N; GRIMM EA; LEE JJ; BEDIKIAN A; ETON O; PAPADOPOULOS N; PLAGER C; LEGHA SS; BENJAMIN RS
      DNA-DAMAGE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH RESPONSE TO BIOCHEMOTHERAPY IN MELANOMA

      Melanoma research
    10. ANDERSON CM; BUZAID AC; SUSSMAN J; LEE JJ; ALIOSMAN F; BRAUNSCHWEIGER PG; PLAGER C; BEDIKIAN A; PAPADOPOULOS N; ETON O; LEGHA SS; GRIMM EA
      NITRIC-OXIDE AND NEOPTERIN LEVELS AND CLINICAL-RESPONSE IN STAGE-III MELANOMA PATIENTS RECEIVING CONCURRENT BIOCHEMOTHERAPY

      Melanoma research
    11. Buzaid, AC; Colome, M; Bedikian, A; Eton, O; Legha, SS; Papadopoulos, N; Plager, C; Ross, M; Lee, JE; Mansfield, P; Rice, J; Ring, S; Lee, JJ; Strom, E; Benjamin, R
      Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

      MELANOMA RESEARCH
    12. LEGHA SS; RING S; ETON O; BEDIKIAN A; BUZAID AC; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA

      Journal of clinical oncology
    13. ETON O; LEGHA SS; MOON TE; BUZAID AC; PAPADOPOULOS NE; PLAGER C; BURGESS AM; BEDIKIAN AY; RING S; DONG Q; GLASSMAN AB; BALCH CM; BENJAMIN RS
      PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED SYSTEMICALLY FOR DISSEMINATED MELANOMA

      Journal of clinical oncology
    14. YEUNG SCJ; ETON O; BURTON DW; DEFTOS LJ; VASSILOPOULOUSELLIN R; GAGEL RF
      HYPERCALCEMIA DUE TO PARATHYROID HORMONE-RELATED PROTEIN SECRETION BYMELANOMA

      Hormone research
    15. LEGHA SS; RING S; ETON O; BEDIKIAN A; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT AND RESULTS OF BIOCHEMOTHERAPY IN METASTATIC MELANOMA - THE UNIVERSITY-OF-TEXAS-M.D.-ANDERSON-CANCER-CENTER EXPERIENCE

      The cancer journal from Scientific American
    16. BEDIKIAN AY; LEGHA SS; ETON O; BUZAID AC; PAPADOPOULOS N; COATES S; SIMMONS T; NEEFE J; VONROEMELING R
      PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA

      Annals of oncology
    17. BUZAID AC; ROSS MI; BALCH CM; SOONG SJ; MCCARTHY WH; TINOCO L; MANSFIELD P; LEE JE; BEDIKIAN A; ETON O; PLAGER C; PAPADOPOULOS N; LEGHA SS; BENJAMIN RS
      CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM

      Journal of clinical oncology
    18. MURRAY JL; KLEINERMAN ES; JIA SF; ROSENBLUM MG; ETON O; BUZAID A; LEGHA S; ROSS MI; THOMPSON L; MUJOO K; RIEGER PT; SALEH M; KHAZAELI MB; VADHANRAJ S
      PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/

      Journal of immunotherapy with emphasis on tumor immunology
    19. LEGHA SS; RING S; BEDIKIAN A; PLAGER C; ETON O; BUZAID AC; PAPADOPOULOS N
      TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA

      Annals of oncology
    20. ETON O; TALPAZ M; LEE KH; ROTHBERG JM; BRELL JM; BENJAMIN RS
      PHASE-II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-2 AND INTERFERON-ALPHA-2A - IMPLICATIONS FOR THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA

      Cancer
    21. TYLER DS; FRANCIS GM; FREDERICK M; TRAN AH; ORDONEZ NG; SMITH JL; ETON O; ROSS M; GRIMM EA
      INTERLEUKIN-1 PRODUCTION IN TUMOR-CELLS OF HUMAN-MELANOMA SURGICAL SPECIMENS

      Journal of interferon & cytokine research
    22. BEDIKIAN AY; WEISS GR; LEGHA SS; BURRIS HA; ECKARDT JR; JENKINS J; ETON O; BUZAID AC; SMETZER L; VONHOFF DD; BENJAMIN RS
      PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY

      Journal of clinical oncology
    23. BUZAID AC; GRIMM EA; ALIOSMAN F; RING S; ETON O; PAPADOPOULOS NE; BEDIKIAN A; PLAGER C; LEGHA SS; BENJAMIN R
      MECHANISM OF THE ANTITUMOR EFFECT OF BIOCHEMOTHERAPY IN MELANOMA - PRELIMINARY-RESULTS

      Melanoma research
    24. UMEZU Y; AUGUSTUS LB; SEITO D; HAYAKAWA K; ROSS MI; ETON O; SWANSON DA; ITOH K
      INCREASE IN THE ABILITY OF HUMAN CANCER-CELLS TO INDUCE CYTOTOXIC T-LYMPHOCYTES BY ULTRAVIOLET-IRRADIATION

      Cancer immunology and immunotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 02:27:13